FI932695A - Angiotensin i kymas-inhibitorer inklusive humant hjaertkymas - Google Patents

Angiotensin i kymas-inhibitorer inklusive humant hjaertkymas Download PDF

Info

Publication number
FI932695A
FI932695A FI932695A FI932695A FI932695A FI 932695 A FI932695 A FI 932695A FI 932695 A FI932695 A FI 932695A FI 932695 A FI932695 A FI 932695A FI 932695 A FI932695 A FI 932695A
Authority
FI
Finland
Prior art keywords
kymas
hjaertkymas
inhibitorer
humant
inklusive
Prior art date
Application number
FI932695A
Other languages
English (en)
Other versions
FI932695A0 (fi
Inventor
Dennis J Hoover
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI932695A0 publication Critical patent/FI932695A0/fi
Publication of FI932695A publication Critical patent/FI932695A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
FI932695A 1992-06-12 1993-06-11 Angiotensin i kymas-inhibitorer inklusive humant hjaertkymas FI932695A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US89772392A 1992-06-12 1992-06-12

Publications (2)

Publication Number Publication Date
FI932695A0 FI932695A0 (fi) 1993-06-11
FI932695A true FI932695A (fi) 1993-12-13

Family

ID=25408314

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932695A FI932695A (fi) 1992-06-12 1993-06-11 Angiotensin i kymas-inhibitorer inklusive humant hjaertkymas

Country Status (5)

Country Link
EP (1) EP0644892A1 (fi)
JP (1) JP2668003B2 (fi)
CA (1) CA2137832C (fi)
FI (1) FI932695A (fi)
WO (1) WO1993025574A1 (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9524267D0 (en) * 1995-11-28 1996-01-31 Isis Innovation Enzyme inhibitor and method
DK0927192T3 (da) * 1996-09-10 2004-09-13 Boehringer Ingelheim Pharma Modificerede aminosyrer, lægemidler indeholdende disse forbindelser og fremgangsmåder til deres fremstilling
ZA979327B (en) * 1996-10-18 1998-05-11 Vertex Pharma Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease.
EP1136498A1 (en) * 1996-10-18 2001-09-26 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases, particularly hepatitis c virus NS3 protease
EP0940400A4 (en) * 1996-10-25 2002-10-02 Mitsubishi Pharma Corp NOVEL HETEROCYCLIC AMIDE COMPOUNDS AND THEIR USE FOR MEDICINAL PURPOSES
US20030069231A1 (en) * 1999-10-12 2003-04-10 Klaus Rudolf Modified aminoacids, pharmaceuticals containing these compounds and method for their production
WO1999041277A1 (fr) * 1998-02-17 1999-08-19 Nippon Kayaku Kabushiki Kaisha Nouveau derive d'acetamide et son utilisation
EP1112749A4 (en) * 1998-08-20 2004-06-16 Senju Pharma Co PROPHYLAXIS OR REMEDIES FOR CIRCULATORY EYE DISTURBANCE
US6432978B1 (en) * 1998-12-01 2002-08-13 Meiji Seika Kaisha, Ltd. SF2809-I,II,III,IV,V and VI substances exhibiting chymase-inhibiting activities
CN1335778A (zh) 1999-11-01 2002-02-13 三得利株式会社 含有糜蛋白酶抑制物质的血管脂质沉积抑制剂
CN1245978C (zh) 2000-02-22 2006-03-22 第一阿斯比奥制药株式会社 含有胃促胰酶抑制剂作为活性成分的预防和治疗各种与嗜酸性粒细胞增多有关的疾病的药物
US6500835B2 (en) 2000-02-22 2002-12-31 Suntory Limited Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient
CN1245979C (zh) 2000-02-22 2006-03-22 第一阿斯比奥制药株式会社 含有胃促胰酶抑制剂作为有效成分的预防和治疗皮炎的药物
JPWO2001083471A1 (ja) * 2000-05-02 2004-04-15 明治製菓株式会社 キマーゼ阻害作用を有する新規インドール誘導体、及びインドール誘導体の製造法
AU2002222933A1 (en) * 2000-07-13 2002-01-30 Millennium Pharamaceuticals, Inc. Inhibitors of factor xa
GB0021315D0 (en) * 2000-08-30 2000-10-18 Dainippon Pharmaceutical Co Heterocyclic compounds and intermediates thereof
US6982348B2 (en) 2001-01-26 2006-01-03 Takeda Pharmaceutical Company Limited Aminoethanol derivatives
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
US7595312B2 (en) 2002-10-25 2009-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
KR101187693B1 (ko) 2003-05-09 2012-10-05 도레이 카부시키가이샤 신장질환의 치료 또는 예방제
UY28500A1 (es) 2003-09-05 2005-04-29 Vertex Pharma Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
DE102004015723A1 (de) 2004-03-29 2005-10-20 Boehringer Ingelheim Pharma Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
JP5517614B2 (ja) * 2006-07-13 2014-06-11 アキリオン ファーマシューティカルズ,インコーポレーテッド ウイルス複製阻害剤としての4−アミノ−4−オキソブタノイルペプチド類
DK2364309T3 (en) 2008-12-10 2015-01-12 Achillion Pharmaceuticals Inc NEW 4-AMINO-4-OXOBUTANOYLPEPTIDER as inhibitors of viral replication
WO2014145600A1 (en) 2013-03-15 2014-09-18 Achillion Pharmaceuticals, Inc. Ach-0142684 sodium salt polymorphs, composition including the same, and method of manufacture thereof
EP2970192A1 (en) 2013-03-15 2016-01-20 Achillion Pharmaceuticals, Inc. Sovaprevir polymorphs and methods of manufacture thereof
US10526315B2 (en) 2016-06-21 2020-01-07 Orion Ophthalmology LLC Carbocyclic prolinamide derivatives
FI3472149T3 (fi) 2016-06-21 2023-11-09 Orion Ophthalmology LLC Heterosyklisiä prolinamidijohdannaisia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499082A (en) * 1983-12-05 1985-02-12 E. I. Du Pont De Nemours And Company α-Aminoboronic acid peptides
CA2021660A1 (en) * 1989-07-26 1991-01-27 Philippe Bey Peptidase inhibitors
HU217612B (hu) * 1991-05-23 2000-03-28 Merrel Dow Pharmaceuticals Inc. Eljárás elasztáz és katepszin G inhibitor hatású peptidek előállítására

Also Published As

Publication number Publication date
CA2137832C (en) 2000-09-26
FI932695A0 (fi) 1993-06-11
JP2668003B2 (ja) 1997-10-27
CA2137832A1 (en) 1993-12-23
EP0644892A1 (en) 1995-03-29
WO1993025574A1 (en) 1993-12-23
JPH07507069A (ja) 1995-08-03

Similar Documents

Publication Publication Date Title
FI932695A (fi) Angiotensin i kymas-inhibitorer inklusive humant hjaertkymas
FI932517A (fi) Antagonister av angiotensin ii
DK88892D0 (da) Forbindelse
AT399443B (de) Sportschuh
FI931711A0 (fi) Stoedfot foer kran i kompositmaterial
FI933038A0 (fi) Matningssystem foer presspartiet i en pappermaskin
ATA236892A (de) Rotornut
FI923709A (fi) I en saekerhetsskena laosbar vagn
FI931058A0 (fi) Rakelbalk foer faergningsanordningen i en tryckmaskin
ATA80192A (de) Rohr-nippel-verbindung
DE59301550D1 (de) Flansch-Rohrverbindung
FI933485A (fi) Avrinningsinsats foer montering i existerande avrinningsbassaeng
ATA227792A (de) Sportschuh
FI925685A0 (fi) Foerfarande i foerbraenningsmotorprocess
FI922527A (fi) Vaeggkonstruktion foer anordning i byggnader
FI291U1 (fi) Utloppsfoerbindning i en substitutionsluftinslaeppningsventil
FI31U1 (fi) Anordning i framlastare
FI377U1 (fi) Bakgrundselement foer vaermebatterier i byggnader
FI420U1 (fi) I en saekerhetsskena laosbar vagn
FI717U1 (fi) Lucka foer montering i takplaot
FI802U1 (fi) Appliceringsbalk i en limpress
FIU920710U0 (fi) Taeckskoeld foer nyckelhaol i foensterbaogar
FI924429A (fi) Anordning i en pappersmaskins inloppslaoda
FIU920151U0 (fi) Skidskors justerbar stoed i fotvalvet
FI925090A0 (fi) Stallarakenne